Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Kevzara 200 mg solution for injection in pre-filled pen

Active Ingredient:
sarilumab
Company:  
SANOFI See contact details
ATC code: 
L04AC14
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Kevzara (sarilumab)- Patient Alert card-Risk Minimisation Information for Patients

This patient alert card contains important safety information that you need to be aware of before, during, and after treatment with KEVZARA For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected] .

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

SANOFI
Company image
Address
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0)800 035 2525
Telephone
+44 (0)118 354 3000